Evidence map›Paper›PMID 40225781›Full record

ArticleChina CDC weekly2025

Cervical Cancer Screening Rates Among Chinese Women - China, 2023-2024.

Mei Zhang, Limin Wang, Xiao Zhang, Chun Li, Zhenping Zhao, Mengting Yu, Maigeng Zhou, Jing Wu, Linhong Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mei ZhangDivision of NCD and Risk Factor Surveillance, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Limin WangNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Xiao ZhangDivision of NCD and Risk Factor Surveillance, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Chun LiDivision of NCD and Risk Factor Surveillance, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhenping ZhaoDivision of NCD and Risk Factor Surveillance, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Mengting YuDivision of NCD and Risk Factor Surveillance, National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Maigeng ZhouNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jing WuNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Linhong WangNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

What is already known about this topic?: The Chinese government has established targets for cervical cancer screening coverage among women of appropriate age: 50% by 2025 and 70% by 2030. Previous data from 2018-2019 indicated that 36.8% of women aged 35-64 years had been screened in China. What is added by this report?: In 2023-2024, screening rates reached 51.5% among women aged 35-64 years, 57.9% among women aged 35-44 years, and 36.8% among women aged 20 years and above. Rural screening coverage (48.2%) approached but remained slightly below the 50% target. Several regions, particularly in the Eastern, Central, and Southern regions have achieved the 2025 target. Significant determinants of low cervical cancer screening coverage among Chinese women encompassed lower educational attainment, unemployment status, limited household income, lack of health insurance coverage, and absence of health check-ups. What are the implications for public health practice?: Intensified implementation of the Action Plan to Accelerate Elimination of Cervical Cancer is needed, particularly in rural areas with suboptimal screening rates. Enhanced health education and service delivery should target women of lower socioeconomic status to facilitate their active participation in screening programs.

Indexed as

cancer screeningcervical cancerChinawomen

Identifiers

PMID40225781
PMCPMC11982917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.